IG Genotype-Repertoire Mapping for Tailored Vaccine Composition
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The complexity of the IG loci and diversity of the antibody repertoire have not been thoroughly explored, limiting the understanding of links between IG polymorphism and antibody repertoire variability, which affects how individuals respond to vaccinations and infections.
Innovation Solution
Methods are developed to identify germ-line polymorphisms at immunoglobulin loci and compare them to antibody repertoires to tailor vaccine compositions for specific subjects or populations, leveraging genotype-repertoire associations for personalized medicine.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional vaccine compositions are used for all subjects, then manufacturing and distribution are simplified, but vaccination efficacy varies due to genetic diversity in IG loci
Solution Approach 1:
The patent segments the population into distinct groups based on their IG locus genotypes (e.g., IGHV1-69 allele presence). Vaccine compositions are then tailored to each segment, with specific antigens or adjuvants selected based on the genetic characteristics of each group. This segmentation allows for improved vaccination efficacy within each genotype group while managing the complexity through systematic classification.
Solution Approach 2:
The patent changes the parameters of vaccine compositions based on subject genotype. Specifically, the presence or absence of certain IGHV alleles (e.g., IGHV1-69) determines which vaccine components are included or excluded. This parameter change approach allows the vaccine formulation to be optimized for each genetic group, improving reliability of efficacy without requiring completely different vaccine platforms.
2Reliability
If personalized vaccine compositions are developed for each subject, then vaccination efficacy is optimized, but the complexity of identifying germ-line polymorphisms and tailoring compositions increases
Solution Approach 1:
The patent extracts and focuses on specific, high-impact germ-line polymorphisms in the IG loci (particularly IGHV1-69 and related alleles) rather than analyzing the entire genome. By identifying and isolating these key genetic markers, the method simplifies the detection process while still enabling personalized vaccine composition development. This extraction approach reduces the complexity of genetic analysis while maintaining the ability to optimize vaccination efficacy.
3Reliability
If vaccine compositions are tailored to specific genotype groups, then immune response is enhanced, but the quantity of different vaccine formulations required increases
Solution Approach 1:
The patent develops a core vaccine formulation that can serve multiple genotype groups, with optional additions or modifications based on specific genetic characteristics. For example, a base vaccine composition is designed to be effective for the majority population, with specific adjuvants or antigen variants added only for subjects with particular IGHV alleles. This multi-functionality approach reduces the total number of distinct vaccine formulations needed while still enhancing immune responses in genotype-specific optimizations.
Data Source
AI summary
The present invention is directed to methods for mining genotype-repertoire-disease associations.